Analyst firms · H.C. Wainwright · BDSI
H.C. Wainwright BDSI price target and rating history
BioDelivery Sciences International Inc. (BDSI) · Health Care
H.C. Wainwright rates BioDelivery Sciences International Inc. (BDSI) Neutral with a $4.50 price target, as of its latest action on Jan 21, 2022. It has published 3 rating actions on BDSI since August 2021, including 0 upgrades and 1 downgrade.
- Current rating
- Neutral
- Price target
- $4.50
- Median target, all firms
- Too few
- Actions on BDSI
- 3
H.C. Wainwright price target on BDSI
Every H.C. Wainwright rating on BDSI
- Jan 21, 2022
- Nov 4, 2021
- Aug 5, 2021
Questions about H.C. Wainwright and BDSI
- What is H.C. Wainwright's price target for BDSI?
- H.C. Wainwright's latest stated price target for BioDelivery Sciences International Inc. (BDSI) is $4.50, from its action on Jan 21, 2022.
- What is H.C. Wainwright's rating on BDSI?
- H.C. Wainwright rates BDSI Neutral, a neutral rating, as of Jan 21, 2022.
- When did H.C. Wainwright last change its view on BDSI?
- On Jan 21, 2022, H.C. Wainwright raises its price target to $4.50 from $4, keeps Neutral.
All H.C. Wainwright ratingsBDSI news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.